Chang B S, Beauvais R M, Dong A, Carpenter J F
Department of Pharmaceutics and Drug Delivery, Amgen, Inc., Amgen Center MS 8-1-A, Thousand Oaks, California, 91320, USA.
Arch Biochem Biophys. 1996 Jul 15;331(2):249-58. doi: 10.1006/abbi.1996.0305.
The effects of glass transition of, and protein conformation in, the dried solid on the storage stability of freeze-dried recombinant human interleukin-1 receptor antagonist (rhIL-1ra) were examined. Glass transition is a temperature-dependent phenomenon. Amorphous materials become hard and brittle at temperatures below their characteristic glass transition temperatures (Tg) such that diffusion of molecules along the matrix is not sufficient to cause large-scale structural changes. To ascertain the importance of the glass transition in protein storage stability, we compared 10 different lyophilized rhIL-1ra formulations, with Tgs ranging from 20 to 56 degrees C, during several weeks of storage at temperatures above and below the samples' Tgs. Protein degradation, both deamidation and aggregation, was greatly accelerated at temperatures above Tg, but for some formulations also arose below Tg. Thus, storage of dried proteins below the Tg is necessary but not sufficient to ensure long-term stability. To examine the effects of protein structure in the dried solid, we prepared formulations with various sucrose concentrations, all of which had a Tg = 66 +/- 2.5 degrees C. With infrared spectroscopy, we determined that the protein lyophilized with </=1% sucrose was unfolded in the initial dried solid. In contrast, in those formulations with >/=5% sucrose, conformational change was inhibited during lyophilization. When stored at 50 degrees C, degradation of the freeze-dried protein varied inversely with sucrose concentration. These results indicate that structural changes arising during the lyophilization process led to damage during subsequent storage, even if the storage temperature was less than the Tg. Together the results of these studies document that to obtain optimum stability of dried rhIL-1ra it was necessary to inhibit conformational change during lyophilization and to store at temperatures below the Tg of the dried formulation.
研究了冻干重组人白细胞介素-1受体拮抗剂(rhIL-1ra)干燥固体中的玻璃化转变及蛋白质构象对其储存稳定性的影响。玻璃化转变是一种温度依赖性现象。无定形材料在低于其特征玻璃化转变温度(Tg)时会变得坚硬易碎,以至于分子沿基质的扩散不足以引起大规模的结构变化。为了确定玻璃化转变对蛋白质储存稳定性的重要性,我们比较了10种不同的rhIL-1ra冻干制剂,其Tg范围为20至56摄氏度,在高于和低于样品Tg的温度下储存数周。蛋白质降解,包括脱酰胺和聚集,在高于Tg的温度下大大加速,但对于某些制剂,在低于Tg的温度下也会发生。因此,将干燥的蛋白质储存在Tg以下是必要的,但不足以确保长期稳定性。为了研究干燥固体中蛋白质结构的影响,我们制备了具有不同蔗糖浓度的制剂,所有制剂的Tg = 66±2.5摄氏度。通过红外光谱,我们确定用≤1%蔗糖冻干的蛋白质在初始干燥固体中是展开的。相反,在那些蔗糖含量≥5%的制剂中,冻干过程中构象变化受到抑制。当在50摄氏度储存时,冻干蛋白质的降解与蔗糖浓度呈反比。这些结果表明,冻干过程中产生的结构变化会导致后续储存过程中的损伤,即使储存温度低于Tg。这些研究结果共同表明,为了获得干燥rhIL-1ra的最佳稳定性,有必要在冻干过程中抑制构象变化,并在低于干燥制剂Tg的温度下储存。